Abiopharma

Imfinzi plus Imjudo combined with lenvatinib and TACE reduced the risk of disease progression or death in EMERALD-3 Phase III trial

Net Asset Value(s)

Actinium Appoints Accomplished Oncology Expert Steffen Heeger MD, MSc as Chief Medical Officer to Drive Rejuvenated Pipeline Development

Amneal Pharmaceuticals, Inc. - Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA® (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting

Waters - Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

Waters - Waters Introduces Unrivaled Sensitivity and Speed to Benchtop HRMS with Xevo MRT P10 MS, Accelerating Multiomics Research

Spectral AI Announces Voting Results of Annual Meeting of Stockholders

GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives

Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing